Rapid Micro Biosystems Inc Total Liabilities

Latest as of June 2026: $40.70 Million USD

Rapid Micro Biosystems Inc total liabilities. Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) has total liabilities worth $40.70 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Rapid Micro Biosystems Inc (RPID) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Rapid Micro Biosystems Inc (2010–2025)

Total liabilities of Rapid Micro Biosystems Inc from 2010 to 2025. This chart illustrates how Rapid Micro Biosystems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore RPID strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Rapid Micro Biosystems Inc Competitors by Total Liabilities

The table below lists competitors of Rapid Micro Biosystems Inc ranked by their total liabilities.

Company Country Total Liabilities
Candles Scandinavia AB Series B
ST:CANDLE-B
Sweden Skr199.15 Million
Aeries Technology Inc.
NASDAQ:AERT
USA $43.82 Million
Woowon Development Co. Ltd
KQ:046940
Korea ₩118.27 Billion
New Advanced Electronics Technologies Co Ltd
TWO:3465
Taiwan NT$1.19 Billion
S. Khonkaen Foods Public Company Limited
BK:SORKON
Thailand ฿1.88 Billion
Kiattana Transport Public Company Limited
BK:KIAT
Thailand ฿112.18 Million
Tubos Reunidos S.A
MC:TRG
Spain €447.35 Million
Kim Hin Industry Bhd
KLSE:5371
Malaysia RM104.34 Million

Liability Composition Analysis (2010–2025)

This chart breaks down Rapid Micro Biosystems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see RPID total assets.

Liquidity & Leverage Metrics

Rapid Micro Biosystems Inc Total Liabilities Ratios Explained

Rapid Micro Biosystems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.70 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rapid Micro Biosystems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rapid Micro Biosystems Inc (2010–2025)

The table below shows the annual total liabilities of Rapid Micro Biosystems Inc from 2010 to 2025.

Year Total Liabilities Change
2025-12-31 $41.65 Million +82.52%
2024-12-31 $22.82 Million -10.39%
2023-12-31 $25.46 Million -3.84%
2022-12-31 $26.48 Million +31.17%
2021-12-31 $20.19 Million -55.31%
2020-12-31 $45.18 Million +39.38%
2019-12-31 $32.41 Million +374.15%
2011-12-31 $6.84 Million +36.12%
2010-12-31 $5.02 Million --

About Rapid Micro Biosystems Inc

NASDAQ:RPID USA Medical Devices
Market Cap
$29.27 Million
Market Cap Rank
#23630 Global
#5129 in USA
Share Price
$0.64
Change (1 day)
+3.39%
52-Week Range
$0.62 - $4.68
All Time High
$24.80
About

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more